Yasunori Kaneko
Director/Board Member at ARCUS BIOSCIENCES, INC.
Net worth: 13 M $ as of 2024-04-29
Yasunori Kaneko active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 2015-04-30 | - |
| Independent Dir/Board Member | 2015-04-30 | - | |
Provigate KK
 Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Director/Board Member | - | - |
Career history of Yasunori Kaneko
Former positions of Yasunori Kaneko
| Companies | Position | Start | End |
|---|---|---|---|
| NIPPON PAINT HOLDINGS CO., LTD. | Director/Board Member | 2018-03-27 | 2020-02-29 |
| Independent Dir/Board Member | 2018-03-27 | 2020-02-29 | |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 1998-12-31 | 2018-12-31 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Director/Board Member | - | 1998-12-31 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 1991-12-31 | 1997-12-31 |
| IONIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 1990-12-31 | 1991-12-31 |
| Paribas Capital Markets | Corporate Officer/Principal | 1986-12-31 | 1990-12-31 |
| H.U. GROUP HOLDINGS, INC. | Director/Board Member | 2010-01-10 | - |
| Independent Dir/Board Member | 2006-05-31 | - | |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Yasunori Kaneko
| Keio University | Doctorate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Statistics
International
| United States | 9 |
| Japan | 5 |
| 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 3 |
| Director of Finance/CFO | 2 |
Sectoral
| Health Technology | 7 |
| Finance | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| H.U. GROUP HOLDINGS, INC. | Health Services |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| NIPPON PAINT HOLDINGS CO., LTD. | Process Industries |
| Private companies | 7 |
|---|---|
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Finance |
Guava Technologies, Inc.
 Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
| Paribas Capital Markets | Finance |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Yasunori Kaneko
- Experience
